Global Viral Vector Production Market Report 2022: Technological Breakthroughs in Vector Manufacturing and a Reliable Pipeline for Gene Treatments and Viral Vector Vaccinations Drives Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Viral Vector Production Market Analysis by Vector Type, by Application, by Workflow, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The viral vector production market size is estimated to be USD 673.4 million in 2021 and is expected to witness a CAGR of 22.72% during the forecast period 2022-2029. The technological breakthroughs in vector manufacturing, reliable pipeline for gene treatments and viral vector vaccinations, and highly competitive market with a variety of techniques employed by market participants are some of the key drivers for the market growth. However, issues with gene therapy and viral vectors in terms of regulation, science, and ethics are expected to restrain the market growth.

Segmentation: Viral Vector Production Market Report 2021-2029

By Vector Type (Revenue, USD Million)

• Lentivirus
• Retrovirus
• Adeno-associated Virus (AAV)
• Adenovirus
• Others

By Application (Revenue, USD Million)

• Biomedical Research
• Vaccine Development
• Cell & Gene Therapy Development
• Biopharmaceutical and Pharmaceutical Discovery

By Workflow (Revenue, USD Million)

• Downstream Processing
• Upstream Processing

By End user (Revenue, USD Million)

• Research Institutes
• Pharmaceutical and Biopharmaceutical Companies

By Region (Revenue, USD Million)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Viral Vector Production

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Viral Vector Production Market

7. Market Analysis by Vector Type

8. Market Analysis by Application

9. Market Analysis by Workflow

10. Market Analysis by End user

11. Regional Market Analysis

12. North America Viral Vector Production Market

11. Europe Viral Vector Production Market

12. Asia PacificViral Vector Production Market

13. Latin America Viral Vector Production Market

14. MEAViral Vector Production Market

15. Competitor Analysis

16. Company Profiles

17. Conclusion & Recommendations

Companies Mentioned

• Lonza (Switzerland)
• Merck (Germany)
• Oxford BioMedica (UK)
• CGT Catapult (UK)
• Cobra Biologics (UK)
• uniQure (Netherlands)
• FUJIFILM Diosynth Biotechnologies (US)
• Spark Therapeutics (US).

For more information about this report visit https://www.researchandmarkets.com/r/aeh078

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900